Clinical Trials in Philadelphia

Showing 14921-14940 of 20,904 trials

A Study of DCC-2701 in Participants With Advanced Solid Tumors

NCT02228811

The main purpose of this study is to investigate the safety of the investigational drug DCC-2701 and whether it will work to help people who have advanced solid tumors or cancer that has spread to other parts of the body.

Locally Advanced TumorsMetastatic Solid TumorsCancers With MET Genomic Alterations+1 more

Deciphera Pharmaceuticals, LLC44 participantsStarted Jun 2014

Aurora, Colorado, United States • Boston, Massachusetts, United States • Philadelphia, Pennsylvania, United States +2 more locations

COMPLETEDPhase 1< 1 mile

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

NCT01460134

This is a study of CDX-1127, a therapy that targets the immune system and may act to promote anti-cancer effects. The study enrolls patients with hematologic cancers (certain leukemias and lymphomas), as well as patients with select types of solid tumors.

CD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more

Celldex Therapeutics90 participantsStarted Oct 2011

Scottsdale, Arizona, United States • Stanford, California, United States • Rochester, Minnesota, United States +7 more locations

A Study of DCC-2701 in Participants With Advanced Solid Tumors

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Find Trials by Condition in Philadelphia

Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci

A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis

Using Feedback Reports to Improve Medication Adherence

Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer

Use of Mindfulness Meditation With Iraqi/Afghanistan War Veterans

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD

NOLAN: Naproxen or Loratadine and Neulasta

Lesinurad and Febuxostat Combination Extension Study in Gout

Venlafaxine for Depression in Alzheimer's Disease (DIADs-3)

Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients

Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)

A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors

Lenalidomide and Idelalisib in Treating Patients With Recurrent Follicular Lymphoma

Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples

AngioDefender Versus Brachial Artery Ultrasound Imaging

A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma

Efficacy and Safety of the Addition of Fluticanse Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide (62.5 or 125mcg) Once-daily Over 12 Weeks